Cargando…

NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer

BACKGROUND AND OBJECTIVE: Nua kinase 1 (NUAK1) was identified in multigene signatures of survival and suboptimal debulking in high-grade serous ovarian cancer (HGSOC). This study investigates the individual clinical and biologic contributions of NUAK1 in HGSOC patients and cell lines. METHODS: Publi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phippen, Neil T., Bateman, Nicholas W., Wang, Guisong, Conrads, Kelly A., Ao, Wei, Teng, Pang-ning, Litzi, Tracy A., Oliver, Julie, Maxwell, G. Larry, Hamilton, Chad A., Darcy, Kathleen M., Conrads, Thomas P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081368/ https://www.ncbi.nlm.nih.gov/pubmed/27833898 http://dx.doi.org/10.3389/fonc.2016.00213

Ejemplares similares

Jupiter microtubule‐associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers
por: Bateman, Nicholas W., et al.
Publicado: (2019)

Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues
por: Penick, Emily R., et al.
Publicado: (2022)

Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes
por: Teng, P-N, et al.
Publicado: (2014)

Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients
por: Bateman, Nicholas W., et al.
Publicado: (2021)

Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study
por: Casablanca, Yovanni, et al.
Publicado: (2022)

Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens
por: Hunt, Allison L., et al.
Publicado: (2021)

NUAK1 and NUAK2 Fine-Tune TGF-β Signaling
por: van de Vis, Reinofke A. J., et al.
Publicado: (2021)

Gene Expression Analysis of Early Stage Endometrial Cancers Reveals Unique Transcripts Associated with Grade and Histology but Not Depth of Invasion
por: Risinger, John I., et al.
Publicado: (2013)

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors
por: Wong, Kwong-Kwok, et al.
Publicado: (2022)

Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer
por: Allard, Jay E., et al.
Publicado: (2012)

State of the ark /
por: Durrell, Lee
Publicado: (1986)

Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer
por: Marcus, Charlotte S, et al.
Publicado: (2014)

Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer
por: Kucera, Calen W., et al.
Publicado: (2023)

Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry
por: Bateman, Nicholas W., et al.
Publicado: (2021)

NUAK Kinases: Brain–Ovary Axis
por: Molina, Ester, et al.
Publicado: (2021)

Calcium signalling links MYC to NUAK1
por: Monteverde, T, et al.
Publicado: (2018)

Brain proteomic atlas of alcohol use disorder in adult males
por: Teng, Pang-ning, et al.
Publicado: (2023)

Identifier mapping performance for integrating transcriptomics and proteomics experimental results
por: Day, Roger S, et al.
Publicado: (2011)

Automated imaging and identification of proteoforms directly from ovarian cancer tissue
por: McGee, John P., et al.
Publicado: (2023)

Author Correction: Automated imaging and identification of proteoforms directly from ovarian cancer tissue
por: McGee, John P., et al.
Publicado: (2023)

NUAK2: an emerging acral melanoma oncogene
por: Namiki, Takeshi, et al.
Publicado: (2011)

NUAK1 links genomic instability and senescence
por: Bernard, David, et al.
Publicado: (2010)

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer
por: Glassman, Deanna, et al.
Publicado: (2022)

Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis
por: Beer, Lucian, et al.
Publicado: (2020)

NUAK2 is a critical YAP target in liver cancer
por: Yuan, Wei-Chien, et al.
Publicado: (2018)

Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
por: Liu, Yuhan, et al.
Publicado: (2023)

The North Area and its Noah's Ark
Publicado: (1977)

The secular ark. Studies in the history of biogeography
por: Desmond, Adrian
Publicado: (1983)

Riders of a Modern-Day Ark
por: Gewin, Virginia
Publicado: (2008)

Arquitectura : escenario para la vida
por: Conrads, Ulrich
Publicado: (1977)

Functional isoeugenol-modified nanogel coatings for implants
por: Conrads, Georg
Publicado: (2017)

A Novel Role for NUAK1 in Promoting Ovarian Cancer Metastasis through Regulation of Fibronectin Production in Spheroids
por: Fritz, Jamie Lee, et al.
Publicado: (2020)

Muscle-specific Knock-out of NUAK Family SNF1-like Kinase 1 (NUAK1) Prevents High Fat Diet-induced Glucose Intolerance
por: Inazuka, Fumika, et al.
Publicado: (2012)

Repeatability of ARK-30 in a pediatric population
por: Hernandez-Moreno, Laura, et al.
Publicado: (2018)

'Van Ark is door de wol geverfd'
por: Ahli, Samira
Publicado: (2021)

In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy
por: Corvigno, Sara, et al.
Publicado: (2023)

Drosophila NUAK functions with Starvin/BAG3 in autophagic protein turnover
por: Brooks, David, et al.
Publicado: (2020)

The impact of ultraviolet- and infrared-based laser microdissection technology on phosphoprotein detection in the laser microdissection-reverse phase protein array workflow
por: Hunt, Allison L., et al.
Publicado: (2020)

Sixteen year-old with leiomyosarcoma in a prior benign myomectomy site
por: Vaz, Jennifer A., et al.
Publicado: (2019)

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients
por: Jackson, Doreen O., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mt40fd6g6qcsr1i2f9estb244m